ADVERTISEMENT

UK to Fund Study on 3rd Dose of COVID-19 Vaccine

Published
UK to Fund Study on 3rd Dose of COVID-19 Vaccine

The British government will fund what it believes to be the world's first study assessing the effectiveness of a third dose of vaccine to combat COVID-19, the UK Budget revealed on Wednesday.

The government is committing 22 million pounds ($30.70 million) to studies that test the effectiveness of a combination of different Covid-19 vaccines. This will also fund the world's first study assessing the effectiveness of a third dose of vaccine to improve the response against current and future variants of Covid-19, according to the Budget.

ADVERTISEMENT

It said 28 million pounds ($39.07 million) will be invested to increase the country's capacity for vaccine testing, support for clinical trials and improve its ability to rapidly acquire samples of new variants of Covid-19, the Xinhua news reported.

The Budget said there will be an extra 1.65 billion pounds ($2.30 billion) of cash injection to ensure the Covid-19 vaccination rollout in England continues to be a success.

Britain started its Covid-19 vaccination program in December, and over 20 million people had received at least the first dose of a vaccine by the end of February.

(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT).

(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)

(The Quint is available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

We'll get through this! Meanwhile, here's all you need to know about the Coronavirus outbreak to keep yourself safe, informed, and updated.

Liked this story? We'll send you more. Subscribe to The Quint's newsletter and get selected stories delivered to your inbox every day. Click to get started.

The Quint is available on Telegram & WhatsApp too, click to join.

Speaking truth to power requires allies like you.
Become a Quint Insider
25
100
200

or more

PREMIUM

3 months
12 months
12 months
Check Insider Benefits
ADVERTISEMENT
Stay Updated

Subscribe To Our Daily Newsletter And Get News Delivered Straight To Your Inbox.

Join over 120,000 subscribers!
ADVERTISEMENT
×
×